StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/3098% above fair value
$3.84−0.15 (-3.76%)

Close on Nov 16, 2026Market cap $1.35BP/E –Yield –

Nuvation Bio total assets

Total assets on the balance sheet at the end of each period.

Nuvation Bio's total assets was $744.50M at Jun 30, 2026. For fiscal 2025 it was $594.82M, up 10.0% from the year before. The highest annual figure on record is $776.15M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$594.82M+10.0%
FY2024Dec 31, 2024$540.63M-13.0%
FY2023Dec 31, 2023$621.48M-7.5%
FY2022Dec 31, 2022$672.14M-13.4%
FY2021Dec 31, 2021$776.15M+249.9%
FY2020Dec 31, 2020$221.79M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$744.50M+15.0%
Q1 FY2026Mar 31, 2026$610.24M+23.9%
Q4 FY2025Dec 31, 2025$594.82M+10.0%
Q3 FY2025Sep 30, 2025$601.56M+5.2%
Q2 FY2025Jun 30, 2025$647.23M+8.8%
Q1 FY2025Mar 31, 2025$492.49M-19.7%
Q4 FY2024Dec 31, 2024$540.63M-13.0%
Q3 FY2024Sep 30, 2024$571.58M-9.4%
Q2 FY2024Jun 30, 2024$594.80M-7.3%
Q1 FY2024Mar 31, 2024$613.13M-6.7%
Q4 FY2023Dec 31, 2023$621.48M-7.5%
Q3 FY2023Sep 30, 2023$630.87M-8.1%
Q2 FY2023Jun 30, 2023$641.41M-10.9%
Q1 FY2023Mar 31, 2023$657.06M-12.6%
Q4 FY2022Dec 31, 2022$672.14M-13.4%
Q3 FY2022Sep 30, 2022$686.49M-14.0%
Q2 FY2022Jun 30, 2022$719.74M-11.6%
Q1 FY2022Mar 31, 2022$751.81M-9.6%
Q4 FY2021Dec 31, 2021$776.15M+249.9%
Q3 FY2021Sep 30, 2021$797.79M+448.3%
Q2 FY2021Jun 30, 2021$814.26M+475757.2%
Q1 FY2021Mar 31, 2021$832.06M–
Q4 FY2020Dec 31, 2020$221.79M–
Q3 FY2020Sep 30, 2020$145.50M–
Q2 FY2020Jun 30, 2020$171.12K–

More Nuvation Bio figures

See a number that looks wrong?